During neonatal mechanical ventilatory support, the delivered nitric oxide concentration is affected by the ventilatory setting

Critical Care Medicine

Volumn 28, Issue 5, 2000, Pages 1607-1611

  Yamaguchi, Nobuyuki ^a   Togari, Hajime ^a   Suzuki, Satoshi ^b  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b Department of Oral and Maxillofacial Surgery   (Japan)

Author keywords

Adverse effects; Chemiluminescence; Drug delivery system; Inhaled nitric oxide; Mechanical ventilatory support; Monitoring; Neonate; Nitric oxide; Persistent pulmonary hypertension of the newborn; Streaming

Indexed keywords

NITRIC OXIDE;

ARTICLE; ARTIFICIAL VENTILATION; CHEMOLUMINESCENCE; DRUG DELIVERY SYSTEM; ENDOTRACHEAL TUBE; HUMAN; NEWBORN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0034112375     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200005000-00058     Document Type: Article

References (19)

1. 1. Ignarro LJ: Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 1989; 65:1-21
2. 2. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526
3. 3. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, et al: Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173-1174
4. 4. Frostell C, Fratacci MD, Wain JC, et al: Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83:2038-2047
5. 5. Roberts JD, Polaner DM, Lang P, et al: Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:818-819
6. 6. Kinsella JP, Neish SR, Shaffer E, et al: Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:819-820
7. 7. Roberts JD, Fineman JR, Zapol WM, et al: Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997; 336:605-610
8. 8. Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997; 336:597-604
9. 9. Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. Pediatrics 1997; 99:838-845
10. 10. Tibballs J, Hochmann M, Carter B, et al: An appraisal of techniques for administration of gaseous nitric oxide. Anaesth Intensive Care 1993; 21:844-847
11. 11. Young JD: A universal nitric oxide delivery system. Br J Anaesth 1994; 73:700-702
12. 12. Young JD, Dyar OJ: Delivery and monitoring of inhaled nitric oxide. Intensive Care Med 1996; 22:77-86
13. 13. Imanaka H, Hess D, Kirmse M, et al: Inaccuracies of nitric oxide delivery systems during adult mechanical ventilatory support. Anaesthesiology 1997; 86:676-688
14. 14. Stenqvist O, Kjelltoft B, Lundin S: Evaluation of a new system for ventilatory administration of nitric oxide. Acta Anaesthesiol Scand 1993; 37:687-691
15. 15. Miller OI, Celermajer DS, Deanfield JE, et al: Guideline for the safe administration of inhaled nitric oxide. Arch Dis Child 1994; 70: F47-F49
16. 16. Dube L, Francoeur M, Troncy E, et al: Comparison of two administration techniques of inhaled nitric oxide on nitrogen dioxide production. Can J Anaesth 1995; 42:922-927
17. 17. Moutafis M, Hatahet Z, Castelain MH, et al: Validation of a simple method assessing nitric oxide and nitrogen dioxide concentrations. Intensive Care Med 1995; 21: 537-541
18. 18. Nelin LD, Christman T, Morrosey JF, et al: Electrochemical nitric oxide and nitrogen dioxide analyzer for use with inhaled nitric oxide. J Appl Physiol 1996; 81:1423-1429
19. 19. Dhillon JS, Kronick JB, Singh NC, et al: A portable nitric oxide scavenging system designed for use on neonatal transport. Crit Care Med 1996; 24:1068-1071